Amazfit expands HYROX athlete roster with five elite competitors

MILPITAS, Calif. - Amazfit, the smart wearables brand owned by Zepp Health (NYSE:ZEPP), a $673 million market cap company whose stock has surged over 1,600% year-to-date according to InvestingPro data, announced Monday it has expanded its roster of sponsored HYROX athletes for the 2025/26 season, bringing back Hunter McIntyre while adding four new competitors.

The expanded team includes returning American athlete McIntyre alongside new additions Rich Ryan (USA), Joanna Wietrzyk (Australia), Emilie Dahmen (Netherlands), and reigning HYROX World Champion Linda Meier (Germany). The sponsorship expansion comes as Zepp Health works to grow its $200 million annual revenue base, though InvestingPro analysis indicates the company faces near-term profitability challenges.

McIntyre, described as "the face of HYROX" in the company statement, will continue using Amazfit’s T-Rex series watches during competition. Ryan, known for his data-driven approach, will utilize the Balance 2 and Helio series products.

Wietrzyk, who finished second in Chicago last season, will sport the Amazfit T-Rex 3. Dahmen, who won two HYROX races in her debut season and placed sixth at the World Championships, will use the Balance 2 and Helio Strap. World Champion Meier relies on both the Helio Strap and T-Rex 3 for performance tracking.

"Our partnership with HYROX is about helping athletes maximize every moment of training, performance, and recovery," said Scott Shepley, Head of Global Marketing of Amazfit, according to the press release.

Amazfit serves as the Official Timing & Wearable Partner of HYROX, a functional fitness racing series that has gained significant popularity in recent years.

The athletes will contribute to product testing and content creation for the brand throughout the season, according to the company statement. For investors interested in deeper analysis of Zepp Health’s financial health and growth prospects, InvestingPro offers comprehensive research reports with detailed metrics and expert insights, available as part of its coverage of over 1,400 US-listed companies.

In other recent news, Zepp Health Corp reported a notable 46% increase in revenue for the second quarter of 2025. This marks the company’s first year-over-year revenue growth since 2021, largely driven by new product launches and improved operational efficiencies. Despite an adjusted operating loss, Zepp Health demonstrated a 42% improvement from the previous year. These developments were well-received in the market, as evidenced by the company’s stock performance. The recent earnings announcement highlights a positive trajectory for Zepp Health, according to the financial results. Investors may find the company’s ability to enhance operational efficiency and launch new products of particular interest. These recent developments provide a snapshot of the company’s current financial health.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.